Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pigment Epithelial Detachment”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Post-approval studies (Phase 4)Study completedNCT01722656
What this trial is testing

Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment

Who this might be right for
Submacular Vascularized Pigment Epithelial Detachments
Southern California Desert Retina Consultants, MC 40
Large-scale testing (Phase 3)Study completedNCT00590694
What this trial is testing

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

Who this might be right for
Age-related Macular DegenerationPigment Epithelial DetachmentNeovascular Macular Degeneration+1 more
Pacific Eye Associates 15
Not applicableUnknownNCT01521819
What this trial is testing

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Who this might be right for
Retinal Pigment Epithelial Detachment With VascularizationAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Post-approval studies (Phase 4)UnknownNCT01670162
What this trial is testing

On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular DegenerationPigment Epithelial Detachment
Tennessee Retina 30
Early research (Phase 1)Study completedNCT00749021
What this trial is testing

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Who this might be right for
Retinal Pigment Epithelial Detachment
Clement K. Chan 40
Testing effectiveness (Phase 2)Study completedNCT00841581
What this trial is testing

Lucentis to Treat Pigment Epithelial Detachment

Who this might be right for
Pigment Epithelial Detachment
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 32
Post-approval studies (Phase 4)Study completedNCT01628354
What this trial is testing

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
University of Melbourne 49
Post-approval studies (Phase 4)Study completedNCT02142296
What this trial is testing

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

Who this might be right for
Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableStudy completedNCT03370380
What this trial is testing

Aflibercept in Patients With Pigment Epithelial Detachments (PED)

Who this might be right for
Pigment Epithelial Detachment
University Hospital Muenster 18
Post-approval studies (Phase 4)WithdrawnNCT01495208
What this trial is testing

Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment

Who this might be right for
Fibrovascular Pigment Epithelial Detachment
Vitreous -Retina- Macula Consultants of New York
Post-approval studies (Phase 4)Study completedNCT00976222
What this trial is testing

Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

Who this might be right for
Pigment Epithelial Detachment
University Hospital Muenster 40
Post-approval studies (Phase 4)WithdrawnNCT01666236
What this trial is testing

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
Federal University of São Paulo
Testing effectiveness (Phase 2)Ended earlyNCT01189019
What this trial is testing

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration

Who this might be right for
Wet Macular DegenerationMacular DegenerationRetinal Pigment Epithelial Detachment
Anne Fung MD 40
Not applicableStudy completedNCT04292756
What this trial is testing

Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment

Who this might be right for
Age-Related Macular Degeneration
The Filatov Institute of Eye Diseases and Tissue Therapy 63
Post-approval studies (Phase 4)Study completedNCT02944227
What this trial is testing

Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Seoul National University Hospital 20